Pathophysiology of Cerebral Malaria: Implications of MSCs as A Regenerative Medicinal Tool

Amrendra Chaudhary1, Poonam Kataria1, Neha Surela1

  • 1Parasite-Host Biology, National Institute of Malaria Research, New Delhi 110077, India.

Insights

Cerebral malaria, a severe Plasmodium falciparum complication, causes neurological damage via brain microvessel adhesion and dysfunction. Mesenchymal stem cells (MSCs) show promise as a regenerative therapy for this condition.

Area of Science:

  • Neurology
  • Immunology
  • Infectious Diseases

Background:

  • Cerebral malaria (CM), a severe Plasmodium falciparum complication, presents as a complex neurological syndrome.
  • CM survivors face risks of cognitive deficits, behavioral issues, and epilepsy, alongside multi-organ dysfunction.
  • Pathogenesis involves infected red blood cell (RBC) adhesion, immune cell accumulation, and coagulation in brain microvasculature, leading to endothelial dysfunction and blood-brain barrier (BBB) impairment.

Purpose of the Study:

  • To review the current understanding of cerebral malaria pathogenesis.
  • To explore the roles of specific factors like NK cells, platelets, ANG-2/ANG-1 ratio, and PfEMP1 in disease progression.
  • To highlight the potential of Mesenchymal stem cells (MSCs) in regenerative medicine for CM.

Main Methods:

  • This is a review article, synthesizing existing research on cerebral malaria.
  • It examines studies on human CM and murine models.
  • It focuses on the molecular and cellular mechanisms underlying CM pathology and potential therapeutic strategies.

Main Results:

  • Brain microvessel adhesion and coagulation, influenced by pathogens and host factors, are critical in CM.
  • Endothelial dysfunction and BBB impairment contribute significantly to neurological damage.
  • Mesenchymal stem cells (MSCs) demonstrate potential therapeutic functions relevant to CM.

Conclusions:

  • Alleviating BBB dysfunction and promoting RBC de-sequestration are potential adjunct therapies for CM.
  • Understanding the roles of specific immune cells and molecular factors is crucial for CM management.
  • Mesenchymal stem cells (MSCs) represent a promising avenue for regenerative therapy in cerebral malaria.